Avantor Revenue 2018-2024 | AVTR

Avantor annual/quarterly revenue history and growth rate from 2018 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Avantor revenue for the quarter ending December 31, 2024 was $1.687B, a 2.1% decline year-over-year.
  • Avantor revenue for the twelve months ending December 31, 2024 was $6.784B, a 2.64% decline year-over-year.
  • Avantor annual revenue for 2024 was $6.784B, a 2.64% decline from 2023.
  • Avantor annual revenue for 2023 was $6.967B, a 7.26% decline from 2022.
  • Avantor annual revenue for 2022 was $7.512B, a 1.71% increase from 2021.
Avantor Annual Revenue
(Millions of US $)
2024 $6,784
2023 $6,967
2022 $7,512
2021 $7,386
2020 $6,394
2019 $6,040
2018 $5,864
2017 $1,247
Avantor Quarterly Revenue
(Millions of US $)
2024-12-31 $1,687
2024-09-30 $1,714
2024-06-30 $1,703
2024-03-31 $1,680
2023-12-31 $1,723
2023-09-30 $1,720
2023-06-30 $1,744
2023-03-31 $1,780
2022-12-31 $1,795
2022-09-30 $1,857
2022-06-30 $1,911
2022-03-31 $1,950
2021-12-31 $1,908
2021-09-30 $1,834
2021-06-30 $1,859
2021-03-31 $1,786
2020-12-31 $1,791
2020-09-30 $1,605
2020-06-30 $1,479
2020-03-31 $1,519
2019-12-31 $1,524
2019-09-30 $1,504
2019-06-30 $1,532
2019-03-31 $1,480
2018-12-31
2018-09-30 $1,494
2018-06-30 $1,478
2017-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $10.289B $6.784B
Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $133.529B 24.94
Elevance Health (ELV) United States $96.108B 12.88
CVS Health (CVS) United States $84.839B 12.41
Cencora (COR) United States $55.604B 20.18
DiDi Global (DIDIY) China $20.317B 29.86
Natera (NTRA) United States $20.018B 0.00
BioMerieux (BMXMF) France $15.594B 0.00
Solventum (SOLV) United States $11.463B 10.69
ICON (ICLR) Ireland $11.251B 10.22
EUROFINS SCIENT (ERFSF) Luxembourg $11.063B 0.00
Revvity (RVTY) United States $11.032B 18.74
CochLear (CHEOY) Australia $10.876B 0.00
Doximity (DOCS) United States $9.934B 51.66
Viatris (VTRS) United States $9.024B 2.85
Medpace Holdings (MEDP) United States $8.956B 23.46
Sonic Healthcare (SKHHY) Australia $7.706B 0.00
HealthEquity (HQY) United States $7.311B 35.97
Charles River Laboratories (CRL) United States $5.209B 10.28
Amplifon S.p.A (AMFPF) Italy $4.285B 22.62
Bausch + Lomb (BLCO) Canada $4.262B 19.45
Alignment Healthcare (ALHC) United States $3.499B 0.00
Sotera Health (SHC) United States $2.975B 17.18
BrightSpring Health Services (BTSG) United States $2.905B 30.18
Organon (OGN) United States $2.868B 2.92
Surgery Partners (SGRY) United States $2.708B 31.21
GeneDx Holdings (WGS) United States $2.680B 318.23
Concentras Parent (CON) United States $2.613B 13.59
Progyny (PGNY) United States $1.837B 40.45
Ardent Health Partners (ARDT) United States $1.786B 0.00
Premier (PINC) United States $1.765B 11.30
GoodRx Holdings (GDRX) United States $1.720B 37.38
Agilon Health (AGL) United States $1.649B 0.00
PACS (PACS) United States $1.411B 0.00
Teladoc Health (TDOC) United States $1.197B 0.00
Pediatrix Medical (MD) United States $1.100B 9.22
Ryman Healthcare (RYHTY) New Zealand $1.035B 0.00
CareDx (CDNA) United States $0.977B 16.62
Establishment Labs Holdings (ESTA) $0.907B 0.00
Nutex Health (NUTX) United States $0.824B 16.14
AMN Healthcare Services Inc (AMN) United States $0.706B 5.59
Embecta (EMBC) United States $0.659B 4.52
Auna S.A (AUNA) Luxembourg $0.515B 13.65
QDM (QDMI) Hong Kong, SAR China $0.496B 0.00
SBC Medicals (SBC) United States $0.417B 0.00
Sonida Senior Living (SNDA) United States $0.405B 0.00
Enhabit (EHAB) United States $0.388B 36.57
InnovAge Holding (INNV) United States $0.372B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.290B 0.00
LifeMD (LFMD) United States $0.242B 0.00
DocGo (DCGO) United States $0.216B 8.83
Performant Healthcare (PHLT) United States $0.195B 0.00
Oncology Institute (TOI) United States $0.163B 0.00
Sera Prognostics (SERA) United States $0.128B 0.00
Beauty Health (SKIN) United States $0.106B 0.00
So-Young (SY) China $0.084B 0.00
Basel Medical Group (BMGL) Singapore $0.082B 0.00
OncoCyte (OCX) United States $0.081B 0.00
Biodesix (BDSX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
IceCure Medical (ICCM) Israel $0.062B 0.00
NeueHealth (NEUE) United States $0.053B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.018B 0.00
ModivCare (MODV) United States $0.014B 4.93
Co-Diagnostics (CODX) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.011B 0.00
KindlyMD (KDLY) United States $0.011B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
Aclarion (ACON) United States $0.005B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00